As dopaminergic neurons are selectively damaged during the progression of PD, Bolognin et al. 461 studied the effect of the LRRK2-G2019S mutation on dopaminergic neurons (Fig. 2g). This evidence concerns the gene LRRK2 and Parkinson disease.